세계의 신장 바이오마커 시장 규모 조사 및 예측 : 바이오마커 유형별, 진단 기술별, 최종 사용자별, 지역별 분석(2022-2029년)

Global Renal Biomarkers Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. A biomarker is a biological characteristic of an organism that is assessed as a sign of typical biological function. Renal biomarkers are a crucial diagnostic tool for identifying both acute and chronic kidney injury as well as several other kidney disorders. Renal disorders are primarily treated using renal biomarkers. These biomarkers are helpful in both research and clinical contexts and are used to analyze the renal system's functionality. The Renal Biomarkers Market is expanding because of factors such as the increasing incidence of various kidney-related diseases, and the increasing rate of progression of chronic kidney disease.

A Kidney International Supplements article from April 2022 claims that millions of people worldwide pass away each year from chronic kidney disease, which affects about 10% of the world's population. Chronic renal disease individuals are becoming more prevalent. Also, compared to Western nations, Asian nations had a significantly higher incidence of diabetes-related chronic renal illnesses. For instance, according to a 2021 report from the International Diabetes Federation, India had an estimated 74,194.7 thousand cases of diabetes in 2021, and by 2030, that number is predicted to rise to 92,973.7 thousand cases. Thus, it is anticipated that over the projection period, demand for renal disease diagnosis would rise in response to the rising prevalence of kidney illnesses and their associated causes. This will fuel the development of biomarkers. Furthermore, advancements in the field of genetic technology strategic activities by market players for product development are creating lucrative growth in the market. However, the high cost of renal biomarkers may halt market growth.

The key regions considered for the Global Renal Biomarkers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

• Abbott Laboratories
• BioPorto Diagnostics AS
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Nexelis (Pacific Biomarkers)
• BioMerieux
• Sphingotec GmbH
• Randox Laboratories Ltd
• Siemens Healthineers AG
• Enzo Life Sciences, Inc.

Recent Developments in the Market:

• In December 2022, the company Journey Biosciences, Inc. has announced the release of NaviDKD, its flagship product, a blood test based on biomarkers that forecast long-term kidney issues in diabetics. The only screening method that gives diabetics a head starts on the risk of developing kidney disease.
• In March 2022, Renalytix plc has announced the launch of myIntelX, a new provider access portal that will enable doctors to order KidneyIntelX prognostic (blood-based biomarker) testing online for more accurate identification of patients at the highest risk of rapid progression of kidney disease in type 2 diabetes.

Global Renal Biomarkers Market Report Scope:

• Historical Data 2019-2020-2021
• Base Year for Estimation 2021
• Forecast period 2022-2029
• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered Biomarker type, Diagnostic Technique, End User, Region
• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Biomarker typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Biomarker Type:

• Functional Biomarker
• Up-regulated Protein
• Other Biomarker Types

By Diagnostic Technique:

• Enzyme-linked Immunosorbent Assay
• Particle-enhanced Turbidimetric Immunoassay (PETIA)
• Colorimetric Assay
• Chemiluminescent Enzyme Immunoassay (CLIA)
• Liquid Chromatography-mass Spectrometry (LS-MS)

By End User:

• Hospitals
• Diagnostic Laboratories
• Other End Users

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Renal Biomarkers Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Renal Biomarkers Market, by Biomarker Type, 2019-2029 (USD Billion)
  • 1.2.3. Renal Biomarkers Market, by Diagnostic Technique, 2019-2029 (USD Billion)
  • 1.2.4. Renal Biomarkers Market, by End User, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Renal Biomarkers Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Renal Biomarkers Market Dynamics

• 3.1. Renal Biomarkers Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of various kidney-related diseases,
    • 3.1.1.2. increasing rate of progression of chronic kidney disease
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Renal Biomarkers
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in the field of genetic technology
    • 3.1.3.2. Strategic activities by market players for product development

Chapter 4. Global Renal Biomarkers Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Renal Biomarkers Market, by Biomarker Type

• 6.1. Market Snapshot
• 6.2. Global Renal Biomarkers Market by Biomarker Type, Performance - Potential Analysis
• 6.3. Global Renal Biomarkers Market Estimates & Forecasts by Biomarker Type 2019-2029 (USD Billion)
• 6.4. Renal Biomarkers Market, Sub Segment Analysis
  • 6.4.1. Functional Biomarker
  • 6.4.2. Up-regulated Protein
  • 6.4.3. Other Biomarker Types

Chapter 7. Global Renal Biomarkers Market, by Diagnostic Technique

• 7.1. Market Snapshot
• 7.2. Global Renal Biomarkers Market by Diagnostic Technique, Performance - Potential Analysis
• 7.3. Global Renal Biomarkers Market Estimates & Forecasts by Diagnostic Technique 2019-2029 (USD Billion)
• 7.4. Renal Biomarkers Market, Sub Segment Analysis
  • 7.4.1. Enzyme-linked Immunosorbent Assay
  • 7.4.2. Particle-enhanced Turbidimetric Immunoassay (PETIA)
  • 7.4.3. Colorimetric Assay
  • 7.4.4. Chemiluminescent Enzyme Immunoassay (CLIA)
  • 7.4.5. Liquid Chromatography-mass Spectrometry (LS-MS)

Chapter 8. Global Renal Biomarkers Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Renal Biomarkers Market by End User, Performance - Potential Analysis
• 8.3. Global Renal Biomarkers Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
• 8.4. Renal Biomarkers Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Diagnostic Laboratories
  • 8.4.3. Other End Users

Chapter 9. Global Renal Biomarkers Market, Regional Analysis

• 9.1. Renal Biomarkers Market, Regional Market Snapshot
• 9.2. North America Renal Biomarkers Market
  • 9.2.1. U.S. Renal Biomarkers Market
    • 9.2.1.1. Biomarker Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Diagnostic Technique breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Renal Biomarkers Market
• 9.3. Europe Renal Biomarkers Market Snapshot
  • 9.3.1. U.K. Renal Biomarkers Market
  • 9.3.2. Germany Renal Biomarkers Market
  • 9.3.3. France Renal Biomarkers Market
  • 9.3.4. Spain Renal Biomarkers Market
  • 9.3.5. Italy Renal Biomarkers Market
  • 9.3.6. Rest of Europe Renal Biomarkers Market
• 9.4. Asia-Pacific Renal Biomarkers Market Snapshot
  • 9.4.1. China Renal Biomarkers Market
  • 9.4.2. India Renal Biomarkers Market
  • 9.4.3. Japan Renal Biomarkers Market
  • 9.4.4. Australia Renal Biomarkers Market
  • 9.4.5. South Korea Renal Biomarkers Market
  • 9.4.6. Rest of Asia Pacific Renal Biomarkers Market
• 9.5. Latin America Renal Biomarkers Market Snapshot
  • 9.5.1. Brazil Renal Biomarkers Market
  • 9.5.2. Mexico Renal Biomarkers Market
  • 9.5.3. Rest of Latin America Renal Biomarkers Market
• 9.6. Rest of The World Renal Biomarkers Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Abbott Laboratories
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. BioPorto Diagnostics AS
  • 10.2.3. F. Hoffmann-La Roche AG
  • 10.2.4. Thermo Fisher Scientific Inc.
  • 10.2.5. Nexelis (Pacific Biomarkers)
  • 10.2.6. BioMerieux
  • 10.2.7. Sphingotec GmbH
  • 10.2.8. Randox Laboratories Ltd
  • 10.2.9. Siemens Healthineers AG
  • 10.2.10. Enzo Life Sciences, Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption